We found the total expression of VEGFR2 in ECs was not changed after NPC-EX treatment, while the expression of p-VEGFR2 was remarkably increased by NPC-EXsmiR-210, indicating the activation of the VEGF/VEGFR2 signal. The gene discussed is VEGFA; the disease is nasopharyngeal carcinoma.